跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AURO-ONDANSETRON ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AURO-ONDANSETRON ODT
Authorized
STANDARD
AURO-ONDANSETRON ODT
auro pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b80a2cee542d6e61
Company
auro pharma inc
Type
Standard
Approval Details
Approval Id
b80a2cee542d6e61
Drug Approval Canada Name
AURO-ONDANSETRON ODT
Product Name
AURO-ONDANSETRON ODT
Status
Marketed
Status Date
2021-12-23
Original Market Date
2021-12-23
Din
02511282
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:22.20
Atc Original
A04AA01 ONDANSETRON
Atc Name
a 04 aa 01
Aig Number
0131120003
Company Name
auro pharma inc
Company Address
3700 Steeles Avenue West, Suite 402, Woodbridge, Ontario, Canada, L4L 8K8
Active Ingredients
ONDANSETRON
4 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b80a2cee542d6e61
Type
Standard
Back to Health Canada Approvals